Synthesis of Drugs/Chemical Substances

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

OFFICE OF DIVERSION CONTROL

Contract Value

Not provided

Codes & Classification
Solicitation Number

15DDHQ26P00000584

NAICS

541380 - Testing Laboratories and Services

Classification Code

Q301

Additional Details
Set Aside

SBA

Place of Performance

West Palm Beach, Florida, UNITED STATES

SourceSAM
Documents2
The Drug Enforcement Administration (DEA), under the Department of Justice, has issued a combined synopsis/solicitation for the procurement of services related to the synthesis of drugs and chemical substances. This opportunity, identified by Procurement Identifier 15DDHQ26P00000584 and SAM.gov Opportunity ID f1a9460175d44f82bd2474343d72093c, is being managed by the DEA’s Office of Diversion Control. The place of performance is specified as West Palm Beach, Florida. Purpose and Scope: The primary objective of this procurement is to engage a qualified contractor to synthesize drugs and chemical substances as required by the DEA. This activity supports the DEA’s mission to enforce controlled substances laws and regulations, and to support investigations and regulatory actions through the provision of synthesized reference materials or substances. The scope of work is commercial in nature and is governed by the requirements set forth in FAR Subpart 12.6, as well as additional DEA-specific clauses and provisions. Key Requirements and Deliverables: Contractors are expected to provide comprehensive synthesis services for drugs and chemical substances, adhering to all applicable federal regulations and DEA standards. The solicitation has been amended to clarify that the requirement is specifically for synthesis services, not DNA testing as previously described. Detailed requirements and deliverables are outlined in the solicitation attachments, which interested parties are encouraged to review for full technical specifications and performance expectations. Contracting Entity and Contact Information: The contracting activity is managed by the DEA’s Office of Diversion Control, a federal office within the Department of Justice. The primary point of contact for this solicitation is Kenny Douangmala, who can be reached via email at [email protected] for any questions or clarifications regarding the opportunity. Classification and Set-Aside: This procurement is classified under NAICS code 541380 (Testing Laboratories and Services), with a business size standard of $41.5 million. The Product Service Code (PSC) is Q301. Importantly, this solicitation is a 100% Small Business Set-Aside, meaning only qualified small businesses are eligible to submit quotes and be considered for award. Procurement Type and Special Considerations: This is a combined synopsis/solicitation, meaning it serves as both the public notice and the request for quotes; no separate written solicitation will be issued. All applicable clauses and provisions are incorporated by reference and can be accessed at www.acquisition.gov. Contractors should note that all terms and conditions remain in effect as per the latest amendment, and compliance with DEA and federal acquisition regulations is mandatory throughout the contract lifecycle. Submission Details: The notice was posted on May 28, 2026, with responses due by June 5, 2026, at 14:06. Interested small businesses should review the full solicitation and attachments available at the provided SAM.gov URL to ensure alignment with their capabilities and to prepare a responsive quote. In summary, this opportunity seeks a small business partner with expertise in the synthesis of drugs and chemical substances, capable of supporting the DEA’s operational and regulatory needs in West Palm Beach, Florida. Contractors with relevant laboratory capabilities and experience in controlled substance synthesis are encouraged to consider this solicitation.